Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | Posard Matthew L.
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | Miyashita Akiko Moni
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | MATSUI CONNIE
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | Krishnan Mahesh
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey...
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | Duncan Barbara Gayle
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-25 | HALOZYME THERAPEUTICS, INC. | Connaughton Berna...
(Director) |
A | Common Stock | A | 6501 | $0.00 - $0.00 | $0 |
| 2024-04-16 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $38.35 - $38.49 | $768,390 |
| 2024-04-16 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $8.11 - $8.11 | $162,200 |
| 2024-03-26 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 11618 | $8.11 - $16.78 | $130,158 |
| 2024-03-12 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $41.64 - $42.27 | $839,100 |
| 2024-03-12 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $8.11 - $12.07 | $227,337 |
| 2024-02-27 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $39.54 - $39.95 | $794,922 |
| 2024-02-28 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 7471 | $8.11 - $8.11 | $60,589 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 10376 | $0.00 - $0.00 | $0 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
F | Common Stock | D | 5257 | $36.10 - $36.10 | $189,777 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard
(SVP, GENERAL COUNSEL) |
M | Common Stock | A | 4796 | $0.00 - $0.00 | $0 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard
(SVP, GENERAL COUNSEL) |
F | Common Stock | D | 2577 | $36.10 - $36.10 | $93,029 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
M | Common Stock | A | 10422 | $0.00 - $0.00 | $0 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
F | Common Stock | D | 5601 | $36.10 - $36.10 | $202,195 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
M | Common Stock | A | 37884 | $0.00 - $0.00 | $0 |
| 2024-02-16 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
F | Common Stock | D | 20362 | $36.10 - $36.10 | $735,068 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 3386 | $0.00 - $0.00 | $0 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
F | Common Stock | D | 5040 | $35.91 - $35.91 | $180,986 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
A | Common Stock | A | 8479 | $0.00 - $0.00 | $0 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
M | Common Stock | A | 1254 | $0.00 - $0.00 | $0 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole
(SVP, CHIEF FINANCIAL OFFICER) |
F | Common Stock | D | 686 | $35.91 - $35.91 | $24,634 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
M | Common Stock | A | 13092 | $0.00 - $0.00 | $0 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
F | Common Stock | D | 24655 | $35.91 - $35.91 | $885,360 |
| 2024-02-15 | HALOZYME THERAPEUTICS, INC. | Torley Helen
(PRESIDENT AND CEO) |
A | Common Stock | A | 32781 | $0.00 - $0.00 | $0 |
| 2024-02-10 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 8133 | $0.00 - $0.00 | $0 |
| 2024-02-10 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
F | Common Stock | D | 2901 | $35.49 - $35.49 | $102,956 |
| 2024-01-16 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $36.00 - $36.00 | $720,000 |
| 2024-01-16 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $12.07 - $12.07 | $241,400 |
| 2023-12-12 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $39.58 - $40.47 | $800,261 |
| 2023-12-12 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $12.07 - $13.81 | $256,246 |
| 2023-11-14 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 20000 | $39.08 - $39.79 | $788,668 |
| 2023-11-14 | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J.
(SVP, CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 20000 | $13.81 - $16.78 | $281,272 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |